Adult-type diffuse gliomas

Clinical trials for Adult-type diffuse gliomas explained in plain language.

Never miss a new study

Get alerted when new Adult-type diffuse gliomas trials appear

Sign up with your email to follow new studies for Adult-type diffuse gliomas, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Terminated 1

Targeted drug pemigatinib tested in brain tumors with specific genetic markers

Disease control Stopped early

This phase 2 trial tested the drug pemigatinib in people with recurrent glioblastoma or other brain tumors that have specific changes in FGFR1-3 genes. Participants took a daily tablet for two weeks followed by one week off. The study aimed to see if the drug could shrink tumors,…

Matched conditions: ADULT-TYPE DIFFUSE GLIOMAS

Phase 2 • Sponsor: Incyte Corporation • Aim: Disease control

Last updated Jun 27, 2026 08:07 UTC

Adult-type diffuse gliomas

Get alerted when new Adult-type diffuse gliomas trials appear

Targeted drug pemigatinib tested in brain tumors with specific genetic markers